A Feasibility Study of Nature-based Health Interventions for People With Mild to Moderate Anxiety, Depression and Stress
Launched by UNIVERSITY OF COPENHAGEN · May 12, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the use of nature-based activities to help people who are experiencing mild to moderate anxiety, depression, or stress. The goal is to see if spending time in nature and engaging in group activities can improve mental health and enhance overall well-being. Up to 120 participants, aged 18 and older, who have been diagnosed with or show symptoms of these mental health conditions, will be invited to join. Participants can come from various sources, such as health centers or self-referrals, and do not need to be on sick leave to qualify.
If you decide to participate, you can expect to join a group of 8-12 people for an engaging program that lasts at least 10 weeks. Each session will last between 1.5 to 2.5 hours and will take place in a safe and supportive outdoor setting. The activities will be tailored to individual needs, focusing on connecting with nature, building social relationships, and promoting physical activity. Throughout the study, researchers will gather feedback and experiences from participants to understand how well these nature-based programs work. Importantly, no one will receive a treatment that is worse than what is currently available, and safety will be a top priority during all activities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or above
- • Diagnosed with or symptoms of mild to moderate anxiety, depression, and/or experiencing symptoms of stress, and as a result is the primary cause of reduced functionality
- • Contact through health center in the municipality, general practitioner, job center, self-referral, or via outpatient psychiatric rehabilitation plan
- • Sick leave is not a requirement
- Exclusion Criteria:
- • Age less than 18 years
- • Serious psychiatric disorders like schizophrenia, bipolar disorder, severe anxiety or depression, posttraumatic stress disorder (PTSD)
- • Suicidal risk
- • Alcohol or substance abuse
About University Of Copenhagen
The University of Copenhagen, a leading research institution in Denmark, is dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including health sciences, pharmacology, and biotechnology, to design and conduct rigorous clinical studies. Committed to ethical standards and scientific integrity, the University of Copenhagen aims to contribute significantly to the global medical community by facilitating groundbreaking research that addresses pressing healthcare challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, , Denmark
Patients applied
Trial Officials
Dorthe V Poulsen, Ass professor
Study Director
Department of Geosciences and Natural Resource Management, University of Copenhagen, Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported